跳至主要内容
临床试验/NCT03705013
NCT03705013终止不适用

Observational Study of Sub-populations From "A Longitudinal Study of Cologuard in an Average Risk Population Assessing a Three Year Test Interval"/Protocol 2014-01 Post-Approval Study

Exact Sciences Corporation20 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2018年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
51
试验地点
20
主要终点
The number of subjects with discordant results that can be attributed to intercurrent disease

研究概览

简要总结

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

详细描述

Subjects who consented to enroll in Exact Sciences Protocol 2014-01, that fit one of the following sub-populations, will be asked to participate in the sub-study. Population 1 includes those whose Cologuard T0 result was positive and colonoscopy result was negative. Population 2 includes those whose Cologuard T0 result was positive and subject declined to complete a colonoscopy per protocol. Population 3 includes those whose Cologuard result at T3 was positive and colonoscopy result at T3 was negative. Population 4 includes those whose Cologuard result at T3 was positive and subject declined to complete a colonoscopy per protocol. Subjects that enrolled in the Exact Sciences Protocol 2014-01, who provided written informed consent to participate in this sub-study, will asked to complete the Follow-Up Questionnaire during a phone interview.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject falls into one of the 4 sub-populations
  • Willing to provide informed consent

排除标准

  • Investigator/sponsor decision
  • Subject withdrew consent

结局指标

主要结局

The number of subjects with discordant results that can be attributed to intercurrent disease

时间窗: 3 years after positive Cologuard result

A medical chart review and phone interview will be conducted for each subject. The Follow-Up Questionnaire will be completed during the phone interview.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验